Circadian murine ouabain chronotolerance revisited

Area of Science:

• Pharmacology
• Chronobiology
• Toxicology

Background:

• Previous studies suggested potential circadian variations in murine susceptibility to ouabain.
• Conventional biometric analysis of intravenous ouabain administration in mice yielded inconclusive results regarding circadian rhythmicity.
• Ouabain is a cardiac glycoside with known toxic effects.

Purpose of the Study:

• To reanalyze existing data on murine susceptibility to intravenously-administered ouabain using cosinor procedures.
• To determine if a statistically significant circadian rhythm exists in susceptibility to ouabain via intravenous injection.
• To compare these findings with previous investigations using different administration routes (intraperitoneal, subcutaneous).

Main Methods:

• Reanalysis of previously collected data on murine ouabain susceptibility.
• Application of cosinor procedures for rhythmometric analysis.
• Comparison of results across different drug administration routes.

Main Results:

• A statistically significant circadian rhythm in murine susceptibility to intravenously-administered ouabain was demonstrated.
• This finding contradicts earlier conclusions of no circadian rhythm for this administration route.
• The results align with previous studies showing circadian rhythms for intraperitoneal and subcutaneous ouabain administration.

Conclusions:

• Murine susceptibility to ouabain is characterized by a circadian rhythm.
• This daily variation in susceptibility is consistent across intravenous, intraperitoneal, and subcutaneous administration routes.
• Cosinor analysis provides a more sensitive method for detecting circadian rhythms in toxicological studies.